Recorded fact · program.covers_drug
program.covers_drug for genentech-access-solutions
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 58828f71 resolves to.
The record
| Fact id | 58828f71b00f3d13fc66d50b |
|---|---|
| Entity | program: genentech-access-solutions |
| Field | program.covers_drug |
| Source | www.gene.com |
| Read on | 2026-11-08T21:45:00.000Z |
| Source version | browser-read-2026-11-08 |
| Method | page-read |
| Verification | verified |
| Licence | facts only (numbers, dates, statuses, hashes); no prose copied; attribution by URL |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
The Genentech medicines supported by the Genentech Patient Foundation are: Actemra® (tocilizumab)* Activase® (alteplase) Alecensa® (alectinib)
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 660d554405b4c2a9e9f81a8b328797d39652c022c965cd3c55db47548a02e33a.
The value
{
"programName": "Genentech Patient Foundation",
"sponsor": "Genentech",
"listKind": "Our Participating Medicines",
"asOf": null,
"drugs": [
{
"name": "Actemra",
"note": "stops accepting new enrollments effective January 1, 2027; all Foundation support ends December 31, 2027"
},
{
"name": "Activase"
},
{
"name": "Alecensa"
},
{
"name": "Avastin"
},
{
"name": "Cathflo Activase"
},
{
"name": "Columvi"
},
{
"name": "Cotellic",
"note": "stops accepting new enrollments effective January 1, 2027; all Foundation support ends December 31, 2027"
},
{
"name": "Enspryng"
},
{
"name": "Erivedge"
},
{
"name": "Evrysdi"
},
{
"name": "Gazyva"
},
{
"name": "Hemlibra"
},
{
"name": "Herceptin"
},
{
"name": "Herceptin Hylecta"
},
{
"name": "Itovebi"
},
{
"name": "Kadcyla"
},
{
"name": "Lucentis"
},
{
"name": "Lunsumio"
},
{
"name": "Ocrevus"
},
{
"name": "Ocrevus Zunovo"
},
{
"name": "Perjeta"
},
{
"name": "Phesgo"
},
{
"name": "PiaSky"
},
{
"name": "Polivy"
},
{
"name": "Pulmozyme"
},
{
"name": "Rituxan"
},
{
"name": "Rituxan Hycela"
},
{
"name": "Rozlytrek"
},
{
"name": "Susvimo"
},
{
"name": "Tecentriq"
},
{
"name": "Tecentriq Hybreza"
},
{
"name": "TNKase"
},
{
"name": "Vabysmo"
},
{
"name": "Venclexta"
},
{
"name": "Xolair"
},
{
"name": "Zelboraf",
"note": "stops accepting new enrollments effective January 1, 2027; all Foundation support ends December 31, 2027"
}
]
}SHA-256 of the exact stored value: d5ab664a416a6d992cdece412a0cc5945ec6ca9ef403bae47f35d519998625df.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.